» Articles » PMID: 32293941

Demographic, Clinical, and Pathologic Features of Patients With Cutaneous Melanoma: Final Analysis of the Brazilian Melanoma Group Database

Abstract

Purpose: National epidemiologic data on melanoma are scarce in Brazil. The current work presents final demographic, clinical, and pathologic results from the Brazilian Melanoma Group database to detail how patients with melanoma present at diagnosis.

Methods: The online database includes patients diagnosed between 1982 and 2015 and evaluated at their centers of origin between 2001 and 2016. The primary objective was to describe the demographic, clinical, and pathologic characteristics of the patients, and secondary objectives were to investigate the association between clinical and pathologic variables of interest.

Results: A total of 1,596 patients were included. Median age was 52 years, 57% were women, and the majority were identified as white. Invasive melanoma was diagnosed in 1,297 patients, mostly localized, whereas 299 (19%) had in situ disease (TisN0M0). Only 165 patients had initial lymph node involvement. Fitzpatrick skin types I or II were slightly more frequent with in situ melanoma (73%) than with invasive disease (67%; = .054). The median Breslow thickness was 0.95 mm, Clark levels 2 and 3 comprised nearly 70% of cases, and ulceration was present in 18% of patients. The mitotic rate was significantly associated with the presence of ulceration and both vascular and perineural invasion but not with margin positivity, whereas histologic regression was associated with both intratumoral and peritumoral inflammatory infiltrates.

Conclusion: Despite the limitations of an observational, registry-based study, the current results provide a general profile of patients with cutaneous melanoma in Brazil at the time of diagnosis.

Citing Articles

Temporal Recurrence of Cutaneous Melanoma: Analysis of a Case Series.

Salomao P, Costa Pimenta M, Wainstein A, Drummond-Lage A J Clin Aesthet Dermatol. 2023; 16(12):32-38.

PMID: 38125669 PMC: 10729801.


Multiple Primary Melanoma: A Five-Year Prospective Single-Center Follow-Up Study of Two MC1R R/R Genotype Carriers.

Sortino A, Soares de Sa B, Martins M, Bertolli E, Paula R, Pinto C Life (Basel). 2023; 13(10).

PMID: 37895483 PMC: 10608495. DOI: 10.3390/life13102102.


Factors Related to Delayed Diagnosis of Cutaneous Melanoma in the Brazilian Public Health System.

Nogueira A, Drummond-Lage A, Ribeiro G, Leite E, Xavier M, Wainstein A J Cancer Educ. 2022; 37(4):1253-1259.

PMID: 35578128 DOI: 10.1007/s13187-022-02176-6.


Birth cohort-specific trends of sun-related behaviors among individuals from an international consortium of melanoma-prone families.

Lacson J, Zamani S, Froes Jr L, Mitra N, Qian L, Doyle S BMC Public Health. 2021; 21(1):692.

PMID: 33888076 PMC: 8063451. DOI: 10.1186/s12889-021-10424-5.

References
1.
Mihm Jr M, Mule J . Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response. Cancer Immunol Res. 2015; 3(8):827-35. PMC: 4527084. DOI: 10.1158/2326-6066.CIR-15-0143. View

2.
Schmerling R, Loria D, Cinat G, Ramos W, Cardona A, Sanchez J . Cutaneous melanoma in Latin America: the need for more data. Rev Panam Salud Publica. 2012; 30(5):431-8. DOI: 10.1590/s1020-49892011001100005. View

3.
Tas F, Erturk K . Presence of histological regression as a prognostic factor in cutaneous melanoma patients. Melanoma Res. 2016; 26(5):492-6. DOI: 10.1097/CMR.0000000000000277. View

4.
Mandala M, Galli F, Cattaneo L, Merelli B, Rulli E, Ribero S . Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases. J Am Acad Dermatol. 2016; 76(2):264-273.e2. DOI: 10.1016/j.jaad.2016.08.066. View

5.
Duprat J, Brechtbulh E, Costa de Sa B, Enokihara M, Humberto Fregnani J, Landman G . Absence of Tumor-Infiltrating Lymphocyte Is a Reproducible Predictive Factor for Sentinel Lymph Node Metastasis: A Multicenter Database Study by the Brazilian Melanoma Group. PLoS One. 2016; 11(2):e0148160. PMC: 4747578. DOI: 10.1371/journal.pone.0148160. View